Ovid Therapeutics Inc.
OVID
$0.3383
-$0.0117-3.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.43M | -32.50M | -29.75M | -50.68M | -52.34M |
| Total Depreciation and Amortization | 613.00K | 593.00K | 570.00K | 559.00K | 568.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.99M | -30.31M | -29.86M | -1.15M | 3.60M |
| Change in Net Operating Assets | -150.00K | 4.36M | 6.13M | 916.00K | 2.39M |
| Cash from Operations | -55.96M | -57.86M | -52.90M | -50.36M | -45.78M |
| Capital Expenditure | -71.00K | -62.00K | -72.00K | -45.00K | -40.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.67M | -15.15M | -19.79M | -12.58M | -2.54M |
| Cash from Investing | 54.59M | -15.21M | -19.87M | -12.62M | -2.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 622.00K | 655.00K | 841.00K | 696.00K | 535.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 30.00M | 30.00M | 30.00M | 30.00M |
| Cash from Financing | 622.00K | 30.66M | 30.84M | 30.70M | 30.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 1.00K | 3.00K | 1.00K |
| Net Change in Cash | -740.00K | -42.42M | -41.93M | -32.28M | -17.83M |